Petia Mitchell

发表

AMG 479, a fully human anti–insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells

R. Radinsky, R. Kendall, R. Baserga, 2009, Molecular Cancer Therapeutics Molecular Cancer Therapeutics.

Listeria monocytogenes personalized cancer vaccines drive therapeutic immune responses to cancer derived neoantigens

J. Johnston, J. DeVoss, J. Lesch, 2020, bioRxiv.

Cancer Therapy : Preclinical Ganitumab ( AMG 479 ) Inhibits IGF-II – Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy

V. Velculescu, D. Slamon, G. Konecny, 2014 .

Local Delivery of OncoVEX Generates SystemicAntitumor ImmuneResponsesEnhanced by Cytotoxic T-Lymphocyte–Associated Protein Blockade

R. Ponce, Tiep Le, Achim K. Moesta, 2017 .

Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors.

E. Lobenhofer, Kristin L. Andrews, B. Herberich, 2015, ACS medicinal chemistry letters.

Running Title: Effects of ganitumab on Igf1R in murine tissues 3

P. Cohen, R. Radinsky, R. Kendall, 2014 .

IGF1R blockade with ganitumab results in systemic effects on the GH-IGF axis in mice.

P. Cohen, R. Radinsky, R. Kendall, 2014, The Journal of endocrinology.

Epitope-Specific Mechanisms of IGF1R Inhibition by Ganitumab

R. Radinsky, R. Kendall, F. Calzone, 2013, PloS one.

Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK).

Kristin L. Andrews, D. Powers, R. Kendall, 2015, Journal of medicinal chemistry.

Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy

V. Velculescu, D. Slamon, G. Konecny, 2014, Clinical Cancer Research.

Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte–Associated Protein Blockade

R. Ponce, Charles Glaus, Tiep Le, 2017, Clinical Cancer Research.

Effect of AMG 479 on anti-tumor effects of gemcitabine and erlotinib against pancreatic carcinoma xenograft models

R. Radinsky, F. Calzone, P. Beltran, 2008 .

Efficacy of Ganitumab (AMG 479), Alone and in Combination with Rapamycin, in Ewing's and Osteogenic Sarcoma Models

R. Radinsky, R. Kendall, F. Calzone, 2011, Journal of Pharmacology and Experimental Therapeutics.

OncoVEXmGM-CSFexpands tumor antigen-specific CD8+ T-cell response in preclinical models

J. DeVoss, J. Werner, J. Estrada, 2023, Journal for ImmunoTherapy of Cancer.

Inhibition of endocrine IGF-1 signaling in normal murine tissues and human tumor xenografts with AMG 479, a fully human anti IGF-1R monoclonal antibody

P. Cohen, R. Radinsky, F. Calzone, 2007 .

Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors.

E. Lobenhofer, B. Herberich, A. Tasker, 2015, ACS Medicinal Chemistry Letters.

AMG 479, a fully human anti–insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells

R. Radinsky, R. Kendall, R. Baserga, 2009, Molecular Cancer Therapeutics Molecular Cancer Therapeutics.

Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte–Associated Protein Blockade

R. Ponce, Charles Glaus, Tiep Le, 2017, Clinical Cancer Research.